Specific organization for in-hospital belatacept infusion to avoid nosocomial transmission during the SARS-CoV-2 pandemic

被引：7

作者：

Kamar, Nassim ^{[1
,2
,3
]}

Esposito, Laure ^{[1
]}

Hebral, Anne L. ^{[1
]}

Guitard, Joelle ^{[1
]}

Del Bello, Arnaud ^{[1
,2
]}

机构：

[1] CHU Rangueil, Dept Nephrol & Organ Transplantat, Toulouse, France

[2] CHU Purpan, INSERM, U1043, IFR BMT, Toulouse, France

[3] Univ Paul Sabatier, Toulouse, France

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷 / 10期

关键词：

clinical research; practice; complication; infectious; immunosuppressant-fusion proteins and monoclonal antibodies; belatacept; immunosuppression; immune modulation; infectious disease;

D O I：

10.1111/ajt.16074

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：2962 / 2963

页数：2

共 2 条

[1] Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic [J].

Gleeson, Shana E. ;

Formica, Richard N. ;

Marin, Ethan P. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (06) :892-895

[2] First case of COVID-19 in a kidney transplant recipient treated with belatacept [J].

Marx, David ;

Moulin, Bruno ;

Fafi-Kremer, Samira ;

Benotmane, Ilies ;

Gautier, Gabriela ;

Perrin, Peggy ;

Caillard, Sophie .

AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (07) :1944-1946

← 1 →